First Header Logo Second Header Logo

Connection

John Parks to Apolipoprotein A-I

This is a "connection" page, showing publications John Parks has written about Apolipoprotein A-I.
Connection Strength

3.939
  1. Mulya A, Lee JY, Gebre AK, Boudyguina EY, Chung SK, Smith TL, Colvin PL, Jiang XC, Parks JS. Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL. J Lipid Res. 2008 Nov; 49(11):2390-401.
    View in: PubMed
    Score: 0.309
  2. Mulya A, Lee JY, Gebre AK, Thomas MJ, Colvin PL, Parks JS. Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1. Arterioscler Thromb Vasc Biol. 2007 Aug; 27(8):1828-36.
    View in: PubMed
    Score: 0.286
  3. Lee JY, Badeau RM, Mulya A, Boudyguina E, Gebre AK, Smith TL, Parks JS. Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice. J Lipid Res. 2007 May; 48(5):1052-61.
    View in: PubMed
    Score: 0.281
  4. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, Parks JS. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest. 2005 May; 115(5):1333-42.
    View in: PubMed
    Score: 0.247
  5. Lee JY, Parks JS. ATP-binding cassette transporter AI and its role in HDL formation. Curr Opin Lipidol. 2005 Feb; 16(1):19-25.
    View in: PubMed
    Score: 0.244
  6. Lee JY, Lanningham-Foster L, Boudyguina EY, Smith TL, Young ER, Colvin PL, Thomas MJ, Parks JS. Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice. J Lipid Res. 2004 Apr; 45(4):716-28.
    View in: PubMed
    Score: 0.227
  7. Chisholm JW, Burleson ER, Shelness GS, Parks JS. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J Lipid Res. 2002 Jan; 43(1):36-44.
    View in: PubMed
    Score: 0.197
  8. Huggins KW, Burleson ER, Sawyer JK, Kelly K, Rudel LL, Parks JS. Determination of the tissue sites responsible for the catabolism of large high density lipoprotein in the African green monkey. J Lipid Res. 2000 Mar; 41(3):384-94.
    View in: PubMed
    Score: 0.174
  9. Huggins KW, Curtiss LK, Gebre AK, Parks JS. Effect of long chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine on the interaction with recombinant high density lipoprotein apolipoprotein A-I. J Lipid Res. 1998 Dec; 39(12):2423-31.
    View in: PubMed
    Score: 0.159
  10. Miller KR, Parks JS. Influence of vesicle surface composition on the interfacial binding of lecithin:cholesterol acyltransferase and apolipoprotein A-I. J Lipid Res. 1997 Jun; 38(6):1094-102.
    View in: PubMed
    Score: 0.144
  11. Parks JS, Gebre AK. Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction. J Lipid Res. 1997 Feb; 38(2):266-75.
    View in: PubMed
    Score: 0.140
  12. Gu X, Wu Z, Huang Y, Wagner MA, Baleanu-Gogonea C, Mehl RA, Buffa JA, DiDonato AJ, Hazen LB, Fox PL, Gogonea V, Parks JS, DiDonato JA, Hazen SL. A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein. J Biol Chem. 2016 Mar 18; 291(12):6386-95.
    View in: PubMed
    Score: 0.131
  13. Parks JS, Li H, Gebre AK, Smith TL, Maeda N. Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma. J Lipid Res. 1995 Feb; 36(2):349-55.
    View in: PubMed
    Score: 0.122
  14. Huang Y, DiDonato JA, Levison BS, Schmitt D, Li L, Wu Y, Buffa J, Kim T, Gerstenecker GS, Gu X, Kadiyala CS, Wang Z, Culley MK, Hazen JE, Didonato AJ, Fu X, Berisha SZ, Peng D, Nguyen TT, Liang S, Chuang CC, Cho L, Plow EF, Fox PL, Gogonea V, Tang WH, Parks JS, Fisher EA, Smith JD, Hazen SL. An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med. 2014 Feb; 20(2):193-203.
    View in: PubMed
    Score: 0.114
  15. Parks JS, Thuren TY. Decreased binding of apoA-I to phosphatidylcholine monolayers containing 22:6 n-3 in the sn-2 position. J Lipid Res. 1993 May; 34(5):779-88.
    View in: PubMed
    Score: 0.108
  16. Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J Lipid Res. 2012 Sep; 53(9):1890-909.
    View in: PubMed
    Score: 0.102
  17. Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr. 2012 Aug 21; 32:161-82.
    View in: PubMed
    Score: 0.101
  18. Liu M, Chung S, Shelness GS, Parks JS. Hepatic ABCA1 and VLDL triglyceride production. Biochim Biophys Acta. 2012 May; 1821(5):770-7.
    View in: PubMed
    Score: 0.097
  19. Chung S, Sawyer JK, Gebre AK, Maeda N, Parks JS. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo. Circulation. 2011 Oct 11; 124(15):1663-72.
    View in: PubMed
    Score: 0.097
  20. Chung S, Gebre AK, Seo J, Shelness GS, Parks JS. A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion. J Lipid Res. 2010 Apr; 51(4):729-42.
    View in: PubMed
    Score: 0.087
  21. Lee JY, Timmins JM, Mulya A, Smith TL, Zhu Y, Rubin EM, Chisholm JW, Colvin PL, Parks JS. HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. J Lipid Res. 2005 Oct; 46(10):2233-45.
    View in: PubMed
    Score: 0.063
  22. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, Eckel RH, Schaefer EJ, Lichtenstein AH. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004 Jun; 24(6):1092-7.
    View in: PubMed
    Score: 0.058
  23. Temel RE, Parks JS, Williams DL. Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase. J Biol Chem. 2003 Feb 14; 278(7):4792-9.
    View in: PubMed
    Score: 0.053
  24. Huggins KW, Colvin PL, Burleson ER, Kelley K, Sawyer JK, Barrett PH, Rudel LL, Parks JS. Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys. J Lipid Res. 2001 Sep; 42(9):1457-66.
    View in: PubMed
    Score: 0.048
  25. Parks JS, Huggins KW, Gebre AK, Burleson ER. Phosphatidylcholine fluidity and structure affect lecithin:cholesterol acyltransferase activity. J Lipid Res. 2000 Apr; 41(4):546-53.
    View in: PubMed
    Score: 0.044
  26. Colvin PL, Moriguchi E, Barrett PH, Parks JS, Rudel LL. Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates. J Lipid Res. 1999 Oct; 40(10):1782-92.
    View in: PubMed
    Score: 0.042
  27. Parks JS, Gebre AK, Furbee JW. Lecithin-cholesterol acyltransferase. Assay of cholesterol esterification and phospholipase A2 activities. Methods Mol Biol. 1999; 109:123-31.
    View in: PubMed
    Score: 0.040
  28. Sorci-Thomas MG, Curtiss L, Parks JS, Thomas MJ, Kearns MW, Landrum M. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation. J Biol Chem. 1998 May 08; 273(19):11776-82.
    View in: PubMed
    Score: 0.038
  29. Sorci-Thomas MG, Curtiss L, Parks JS, Thomas MJ, Kearns MW. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity. J Biol Chem. 1997 Mar 14; 272(11):7278-84.
    View in: PubMed
    Score: 0.035
  30. Smoak KA, Aloor JJ, Madenspacher J, Merrick BA, Collins JB, Zhu X, Cavigiolio G, Oda MN, Parks JS, Fessler MB. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 2010 Jun 09; 11(6):493-502.
    View in: PubMed
    Score: 0.022
  31. Maitra U, Parks JS, Li L. An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2. Mol Cell Biol. 2009 Nov; 29(22):5989-97.
    View in: PubMed
    Score: 0.021
  32. Singaraja RR, Van Eck M, Bissada N, Zimetti F, Collins HL, Hildebrand RB, Hayden A, Brunham LR, Kang MH, Fruchart JC, Van Berkel TJ, Parks JS, Staels B, Rothblat GH, FiƩvet C, Hayden MR. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo. Circulation. 2006 Sep 19; 114(12):1301-9.
    View in: PubMed
    Score: 0.017
  33. Parks JS, Rudel LL. Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the nonhuman primate. J Lipid Res. 1985 Jan; 26(1):82-91.
    View in: PubMed
    Score: 0.015
  34. Parks JS, Rudel LL. Metabolism of the serum amyloid A proteins (SSA) in high-density lipoproteins and chylomicrons of nonhuman primates (vervet monkey). Am J Pathol. 1983 Sep; 112(3):243-9.
    View in: PubMed
    Score: 0.014
  35. Parks JS, Rudel LL. Different kinetic fates of apolipoproteins A-I and A-II from lymph chylomicra of nonhuman primates. Effect of saturated versus polyunsaturated dietary fat. J Lipid Res. 1982 Mar; 23(3):410-21.
    View in: PubMed
    Score: 0.012
  36. Parks JS, Rudel LL. Detection of immunological heterogeneity of an isolated, purified protein (vervet apolipoprotein A-I). Biochim Biophys Acta. 1980 May 28; 618(2):327-36.
    View in: PubMed
    Score: 0.011
  37. Sorci-Thomas MG, Parks JS, Kearns MW, Pate GN, Zhang C, Thomas MJ. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression. J Lipid Res. 1996 Mar; 37(3):673-83.
    View in: PubMed
    Score: 0.008
  38. Wrenn SM, Parks JS, Immermann FW, Rudel LL. ACAT inhibitors CL 283,546 and CL 283,796 reduce LDL cholesterol without affecting cholesterol absorption in African green monkeys. J Lipid Res. 1995 Jun; 36(6):1199-210.
    View in: PubMed
    Score: 0.008
  39. Ettinger WH, Varma VK, Sorci-Thomas M, Parks JS, Sigmon RC, Smith TK, Verdery RB. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler Thromb. 1994 Jan; 14(1):8-13.
    View in: PubMed
    Score: 0.007
  40. Carr TP, Traber MG, Haines JL, Kayden HJ, Parks JS, Rudel LL. Interrelationships of alpha-tocopherol with plasma lipoproteins in African green monkeys: effects of dietary fats. J Lipid Res. 1993 Nov; 34(11):1863-71.
    View in: PubMed
    Score: 0.007
  41. Wolfe MS, Parks JS, Morgan TM, Rudel LL. Age and dietary polyunsaturated fat alter high density lipoprotein subfraction cholesterol concentrations in a pediatric population of African green monkeys. Arterioscler Thromb. 1991 May-Jun; 11(3):617-28.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.